Matsumoto Takayuki, Lida Mitsuo, Kobori Yoichiro, Mizuno Mitsuru, Nakamura Shotaro, Hizawa Kazuoki, Yao Takashi
Department of Endoscopic Diagnostics and Therapeutics, Kyushu University Hospital, Fukuoka, Japan.
Am J Gastroenterol. 2002 Jan;97(1):180-5. doi: 10.1111/j.1572-0241.2002.05434.x.
In familial adenomatous polyposis (FAP), genetic predisposition for duodenal adenomatosis has not been investigated precisely. The aim of this study was to investigate the correlation between adenomatous polyposis coli (APC) gene mutation and duodenal adenomatosis in FAP.
APC gene mutation was determined by means of a protein truncation test in 34 patients from 25 families with FAP. The prevalence and grade of duodenal adenomatosis were compared among the proximal mutation group (exons 1-9), the distal mutation group (exons 10-15), and the undetermined groups. The correlation between the course of duodenal adenomatosis and APC gene mutation was retrospectively investigated in 19 patients.
The prevalence of duodenal adenomatosis was lower in the proximal mutation group (44%) than in the distal mutation (100%) and undetermined (83%) groups. In patients with positive duodenal adenomatosis, the endoscopic grade did not differ among the groups. The endoscopic grade increased in two of the four patients with the proximal mutation group (50%), in three of 10 patients with the distal mutation group (30%), and in two of five patients (40%) with the undetermined group.
Truncating APC gene mutation proximal to exon 9 may contribute to the less frequent development of duodenal adenomatosis in FAP, but severity and progression of duodenal adenomatosis do not seem to be determined by APC gene mutation alone.
在家族性腺瘤性息肉病(FAP)中,尚未对十二指肠腺瘤病的遗传易感性进行精确研究。本研究的目的是调查FAP中腺瘤性息肉病 coli(APC)基因突变与十二指肠腺瘤病之间的相关性。
通过蛋白质截短试验对来自25个FAP家族的34例患者进行APC基因突变检测。比较近端突变组(外显子1 - 9)、远端突变组(外显子10 - 15)和未确定组中十二指肠腺瘤病的患病率和分级。对19例患者回顾性研究十二指肠腺瘤病病程与APC基因突变之间的相关性。
近端突变组十二指肠腺瘤病的患病率(44%)低于远端突变组(100%)和未确定组(83%)。在十二指肠腺瘤病阳性的患者中,各组内镜分级无差异。近端突变组4例患者中有2例(50%)内镜分级升高,远端突变组10例患者中有3例(30%),未确定组5例患者中有2例(40%)。
外显子9近端的APC基因截短突变可能导致FAP中十二指肠腺瘤病的发生频率较低,但十二指肠腺瘤病的严重程度和进展似乎并非仅由APC基因突变决定。